CB2 Insights partners with Freas Medical Advisors to expand healthcare services in Maryland

TORONTO: CB2 Insights has entered into a Business Services Agreement with the Freas Medical Advisors (FMA) to expand medical services in Maryland. FMA is also investigating geographic expansion of its relationship with CB2 across other US States, a news release said.

As part of CB2’s Direct Primary Care services (DPC), patients pay an annual fee of $199 per year for unlimited access to a network of healthcare providers for a range of primary care and urgent care needs.

Additionally, the Company offers additional insurable services on a fee for service basis. In partnership with FMA, CB2 will benefit from direct access to a network of pain management, general healthcare, and nursing home facilities servicing thousands of patients per year, seeking complementary healthcare offerings.

FMA represents a team of healthcare entrepreneurs who bring over 40 years of experience in business and US healthcare operations. With strong ties to regulatory bodies within Maryland, the FMA network of practices include Novus Pain Management Center and Flagship Rehabilitation, among others. In addition to building a strong patient referral network, FMA will leverage its connections, network, and resources to help build and maintain a strong business model for CB2 in Maryland.

In coordination with this partnership, Dr. Haroon Hameed will take the role of Medical Director for Maryland for CB2’s medical services business. Dr. Hameed is a board-certified Physical Medicine and Rehabilitation doctor with over 7 years as an Interventional Pain Specialist in Florida, Maryland, and Virginia.

In addition to supporting clinical efforts, Dr. Hameed will also play a critical role in supporting CB2’s research initiatives in Maryland and has co-authored a number of peer-reviewed publications to date.

“We are beyond excited to be working with FMA in Maryland. It is one of the leading healthcare groups in the state and greatly accelerates CB2’s growth therein. Its strong ties to community healthcare networks, regulatory bodies and proven business acumen are going to significantly help in CB2’s strategy to become a leader in US integrative healthcare. We are hopeful that this partnership model in Maryland can be replicated across the other 11 states in which CB2 operates.” said Prad Sekar, CEO, CB2 Insights.

“The FMA has been active in the US healthcare space for over 40 years. Our goal is to continue to build new innovative healthcare models that will help the overall improvement of patient health outcomes. What CB2 is offering with its unique DPC and insurable services model, coupled with their approach to integrative healthcare and alternative therapies aligns well with what we believe will be a key driver in the post-COVID US healthcare environment, and we are looking forward to actively building on this vision with them,” said Dustin Freas, Executive Director, Freas Medical Advisors.

CB2 Insights (CSE:CBII OTCQB:CBIIF) CB2 Insights is a healthcare services and technology company, working to positively impact patient health outcomes.

To support patient care and positive health outcomes, the Company is also focused on advancing safety and efficacy research surrounding alternative health treatments by monitoring and assessing Real-World Data (RWD) and providing Real-World Evidence (RWE) through our proprietary technology, data analytics, and a full service contract research organization.


Leave a Reply

Your email address will not be published. Required fields are marked *